Alan Xu

568 total citations
12 papers, 458 citations indexed

About

Alan Xu is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Alan Xu has authored 12 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Rheumatology. Recurrent topics in Alan Xu's work include Mast cells and histamine (5 papers), Asthma and respiratory diseases (3 papers) and interferon and immune responses (2 papers). Alan Xu is often cited by papers focused on Mast cells and histamine (5 papers), Asthma and respiratory diseases (3 papers) and interferon and immune responses (2 papers). Alan Xu collaborates with scholars based in China, United States and Australia. Alan Xu's co-authors include Lingling Zhou, Xiang Wang, Baoping Jiang, Julia Schanin, Wouter Korver, John Leung, Bradford A. Youngblood, Emily C. Brock, Simon Gebremeskel and Bruce S. Bochner and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and Biochemical Pharmacology.

In The Last Decade

Alan Xu

11 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Xu China 10 237 135 115 66 56 12 458
María Jesús Domínguez‐Luis Spain 10 167 0.7× 82 0.6× 122 1.1× 39 0.6× 12 0.2× 13 437
Daniel Regan-Komito United Kingdom 10 211 0.9× 144 1.1× 43 0.4× 36 0.5× 16 0.3× 16 414
Stéphane Jemelin Switzerland 13 249 1.1× 201 1.5× 17 0.1× 88 1.3× 25 0.4× 17 499
David E. Dobbins United States 9 94 0.4× 125 0.9× 81 0.7× 49 0.7× 21 0.4× 16 382
Péter Pócza Hungary 12 229 1.0× 176 1.3× 30 0.3× 49 0.7× 12 0.2× 15 486
Martina Meßner Germany 8 200 0.8× 125 0.9× 19 0.2× 30 0.5× 20 0.4× 9 434
Tatsuya Sasakawa Japan 12 102 0.4× 291 2.2× 97 0.8× 44 0.7× 10 0.2× 13 633
Yanhong Liu China 14 116 0.5× 176 1.3× 110 1.0× 31 0.5× 17 0.3× 31 485
Susanne Aschermann Germany 7 333 1.4× 163 1.2× 27 0.2× 42 0.6× 13 0.2× 9 506
Marcela T Taruselli United States 11 315 1.3× 108 0.8× 55 0.5× 116 1.8× 8 0.1× 21 467

Countries citing papers authored by Alan Xu

Since Specialization
Citations

This map shows the geographic impact of Alan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Xu more than expected).

Fields of papers citing papers by Alan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Xu. The network helps show where Alan Xu may publish in the future.

Co-authorship network of co-authors of Alan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Xu. A scholar is included among the top collaborators of Alan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Xu. Alan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Morgenstern, Netali Ben-Baruch, Yun Cao, Rebecca A. Krier-Burris, et al.. (2022). Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells. Cells. 11(7). 1138–1138. 25 indexed citations
2.
Korver, Wouter, Simon Gebremeskel, Gian Luca Negri, et al.. (2022). The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation. Frontiers in Immunology. 13. 833728–833728. 27 indexed citations
3.
Schanin, Julia, Wouter Korver, Emily C. Brock, et al.. (2022). Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells. Communications Biology. 5(1). 1226–1226. 17 indexed citations
4.
Xu, Alan, et al.. (2022). Macrophage targeted triptolide micelles capable of cGAS-STING pathway inhibition for rheumatoid arthritis treatment. Journal of drug targeting. 30(9). 961–972. 19 indexed citations
5.
Benet, Zachary, et al.. (2022). Mast Cells are Locally Activated and Respond to MRGPRX2 Stimulation in Atopic Dermatitis Ex Vivo Skin Biopsies. Journal of Allergy and Clinical Immunology. 149(2). AB5–AB5. 5 indexed citations
6.
Gebremeskel, Simon, Julia Schanin, Krysta M. Coyle, et al.. (2021). Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody. Frontiers in Immunology. 12. 650331–650331. 86 indexed citations
8.
Schanin, Julia, Simon Gebremeskel, Wouter Korver, et al.. (2020). A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation. Mucosal Immunology. 14(2). 366–376. 60 indexed citations
9.
Wang, Xiang, et al.. (2020). MicroRNA let-7g-5p alleviates murine collagen-induced arthritis by inhibiting Th17 cell differentiation. Biochemical Pharmacology. 174. 113822–113822. 28 indexed citations
10.
Xu, Alan, et al.. (2019). Zishen Tongluo formula ameliorates collagen-induced arthritis in mice by modulation of Th17/Treg balance. Journal of Ethnopharmacology. 250. 112428–112428. 28 indexed citations
11.
Xu, Alan, et al.. (2019). Th17 cell pathogenicity and plasticity in rheumatoid arthritis. Journal of Leukocyte Biology. 106(6). 1233–1240. 142 indexed citations
12.
Zheng, Yi, Shue Wang, Xufeng Xue, et al.. (2017). Notch signaling in regulating angiogenesis in a 3D biomimetic environment. Lab on a Chip. 17(11). 1948–1959. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026